Description
NOBIVAC® CANINE 1-DAPPVL2
Reg. No. G3896 (Act 36/1947)
Namibia Reg. No. V04/24.1/905 [NS2]
This vaccine may only be used by or under the supervision of persons registered in terms of or authorised in terms of section 23 (1) (c) of the Veterinary and Para-Veterinary Professions Act, 1982 (Act No. 19 of 1982).
INDICATIONS
A modified live vaccine for the immunisation of healthy dogs against canine distemper, adenovirus type 2, infectious canine hepatitis, parainfluenza, parvovirus and leptospirosis.
COMPOSITION
Modified live vaccine containing canine distemper virus, canine adenovirus type 2, canine parainfluenza virus and canine parvovirus type 2b strain and inactivated Leptospira (L. canicola and L. icterohaemorrhagiae) bacterin.
Maximum moisture content at release: ≤ 5,5 %.
Contains gentamicin and thimerosal as preservatives.
STORAGE
- Store between 2 °C and 8 °C.
- Do not freeze.
- Protect from light.
WARNINGS
- DO NOT VACCINATE PREGNANT BITCHES.
- Vaccinate only healthy, non-parasitised dogs.
- Destroy any unused vaccine and dispose of all the empty vaccine containers and disposable equipment after use in accordance with National Environmental Management: Waste Act, 2008 (Act No. 59 of 2008).
- KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
- Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.
